A practical guideline on the fertility-sparing treatment of patients with endometrial carcinoma and atypical endometrial hyperplasia
- PMID: 40071490
- DOI: 10.1002/ijgo.70059
A practical guideline on the fertility-sparing treatment of patients with endometrial carcinoma and atypical endometrial hyperplasia
References
REFERENCES
-
- Rodolakis A, Scambia G, Planchamp F, et al. ESGO/ESHRE/ESGE guidelines for the fertility‐sparing treatment of patients with endometrial carcinoma. Int J Gynecol Cancer. 2023;33(2):208‐222.
-
- Abu‐Rustum N, Yashar C, Arend R, et al. Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2023;21(2):181‐209.
-
- Giampaolino P, Di Spiezio Sardo A, Mollo A, et al. Hysteroscopic endometrial focal resection followed by levonorgestrel intrauterine device insertion as a fertility‐sparing treatment of atypical endometrial hyperplasia and early endometrial cancer: a retrospective study. J Minim Invasive Gynecol. 2019;26(4):648‐656.
-
- Casadio P, Raffone A, Salucci P, et al. Visual dilation and curettage for the fertility‐sparing treatment of atypical endometrial hyperplasia/endometrial intra‐epithelial neoplasia: an easy to perform in‐office technique. Int J Gynecol Cancer. 2023;33(5):837‐838.
-
- Catena U, Mirandola M, Capomacchia FM, Fanfani F, Scambia G. A new surgical approach for fertility‐sparing management of diffuse endometrial G2 endometrioid adenocarcinoma: a step‐by‐step technique. Facts Views Vis Obgyn. 2023;15(1):79‐81.
Publication types
LinkOut - more resources
Full Text Sources
